September 2025

Semaglutide & frail heart failure patients | AI turns mammograms into CVD risk assessments | Regeneron gains a key FDA approval ()
FDA clears new platform for AI heart assessments | Big news for Mount Sinai | Surgeons share their perspective ()
Potential new tariffs for all medical devices | Mavacamten & nonobstructive HCM | AI delivers—but not every time ()
Week in Review: FDA reviews patient injuries | America’s heart failure epidemic | A new recall | A call to action | TAVR trends ()
1 in 4 Americans will develop heart failure | Nasal spray approved for CHF-related edema | New data on semaglutide & tirzepatide ()
CVD causes 1 in 3 deaths | Recruiting during a physician shortage | A call to action | TAVR & excessive cusp calcification ()
TAVR reinterventions over time | ACC shares tricuspid valve recommendations | Semaglutide comes out on top ()
Multimodality imagers playing a critical role | FDA clears AI platform for heart assessments | ASNC wants to fight back ()
Heart pump controllers recalled | Incoming ASNC president looks ahead | Device issue linked to 5 injuries | Heartflow's big news ()
America’s heart failure epidemic | SCAI takes on shock-related mortality | Medtech companies team up | AR & ablation ()
Boston Scientific scoops up medtech business | Doc sentenced to prison | High drug costs limit access ()
TAVR & CAS | Imaging groups share new flurpiridaz guideline | Oral semaglutide & weight loss | Top heart hospital opens AI lab ()
Most popular cardiology video interviews this past month ()
Week in Review: Doc sues hospital | New device recalls | FDA clears Apple algorithm for hypertension | AI's potential ()
CMS proposes performing cardiac ablations at ASCs | A warning from Abbott | Defibrillation leads recalled | LVDF & AFib ()
Cutting PAD amputation rates in half | Abbott sends warning about EP catheters | ACC to UN: More healthcare workers needed ()
FDA takes on unauthorized BP devices | Registry helps hospitals expand outpatient services | A key approval for Medtronic ()
Preparing for cath lab complications | Self-expanding stents recalled | New DanGer Shock data | Big news for Shockwave Medical ()
Medline recalls surgical kits | Rethinking device approvals in Europe | FDA approves nasal spray for HF-related edema ()
Cardiologist sues hospital | Catheter recall may result in shortage | AI's potential | Boosting surgery volumes ()
Defibrillation leads recalled | Multimodality imagers making an impact | FDA clears hypertension alerts | IVL in Europe ()
Plant-based diets linked to lower risk of heart disease | Safety risk results in recall | Oral GLP-1 drug impresses again ()
Dexcom issues a new recall | Cardiologist sues hospital | Why heart patients should be vaccinated | Surgeon opinions on AI ()
Week in Review: Catheters recalled | Cardiac ablations at ASCs | FDA clears new PFA system | Apple takes on hypertension ()
Self-expanding stents recalled due to risk of ‘serious harm' | New York cardiologist heads to prison | A key approval for Abbott ()
Apple takes on hypertension | Key takeaways from ASNC 2025 | Open-source AI delivers | FDA clears cardiac imaging platform ()
ASNC ready to fight against cuts | Plant-based diets linked to many benefits | Boston Scientific inks $88M deal | CRF's new hire ()
TAVR Highlights: Treating patients with nickel allergies | Medtronic receives updated FDA approval | No sedation required? ()
First study of its kind examines hypoplastic left heart syndrome | TAVR & nickel allergies | LVDF & AFib | New M-TEER data ()
The potential impact of ablations being performed in ASCs | A key DanGer Shock update | FDA clears new robotic system ()
FDA announces new Class I catheter recalls | Hypertension guidelines embrace early treatment | Palliative care & heart failure ()
FDA clears new AI-enabled CCTA scanner | New PFA catheter integrates high-density mapping | Electrosurgical cuts boost TAVR ()
Week in Review: CCTA staffing shortages | DCBs make little impact in PAD | Beta-blockers had no impact on heart attack patients ()
Stents recalled | New hypertension guidelines | RDN tech gains key approvals | Insulin pump error linked to 700 adverse events ()
News Alert: FDA announces Class I recalls due to safety issue with Medtronic catheters ()
3D echo increasingly used for congenital surgery| First robotic high density EP mapping | Smart telemetry cardiac monitoring ()
IVL & mitral valve disease | The STS/ACC TVT Registry | Surgeons perform first robotic AVR of its kind | Previewing TCT 2025 ()
ESC has record attendance | How to address CCTA staffing issues | FDA clears large-bore PE thrombectomy catheter ()
Beta blockers ‘have no effect’ | Semaglutide & tirzepatide boost HF outcomes | DCBs make little impact | Big news for Medtronic ()
AI now embedded in nearly every cardiovascular IT system | Heartflow raises $364M with IPO | Early heart failure screening ()
Recor Medical gains historic approval | GE HealthCare launches new ultrasound tech | Sedation vs. local anesthesia during TAVR ()
August's Top Stories: A new Watchman risk | Device recalls | Cardiologist to pay $1.2M | PFA & nerve damage | LAAO guidelines ()